Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COVID-19: Page 3
FDA authorizes Discover Labs to run molecular COVID-19 test at its Texas facility
By
Nick Paul Taylor
Under the terms of the EUA, Discover Labs can run the COVID-19 test at its CLIA-certified Austin facility. The test is for prescription use only.
July 7, 2023
Georgia urgent care chain to pay $1.6M to resolve lawsuits involving COVID-19 testing, treatment
By
LabPulse.com staff writers
This civil settlement resolves lawsuits filed in the U.S. District Court for the Northern District of Georgia by former employees of CRH Healthcare under whistleblower provisions of the False Claims Act.
June 22, 2023
Lab billing firm settles lawsuit related to unnecessary COVID-19 testing
By
LabPulse.com staff writers
For one chain of communities, a laboratory directed the company to bill Medicare for respiratory pathogen panels ordered by a physician who had not ordered the tests.
June 20, 2023
Many clinicians experienced suicidal thoughts during pandemic
By
Elissa Wolfson
One in ten National Health Service healthcare workers experienced suicidal thoughts during the first year of the COVID-19 pandemic, according to a study.
June 21, 2023
Arkansas man sentenced in $134M healthcare fraud, money laundering scheme connected with lab testing
By
LabPulse.com staff writers
With colleagues, the man submitted more than $134 million in false and fraudulent claims to Medicare in connection with diagnostic laboratory testing during the COVID-19 pandemic.
June 9, 2023
Quantification of long COVID fatigue shows impact is worse than some cancers
By
Nick Paul Taylor
Fatigue is the most impactful symptom in the lives of people suffering from long COVID, with patients reporting worse scores than individuals with some cancers.
June 8, 2023
Taking metformin during SARS-CoV-2 infection cuts risk of long COVID in clinical trial
By
Nick Paul Taylor
The study was primarily designed to assess whether metformin, ivermectin, or fluvoxamine can prevent serious SARS-CoV-2 infection in non-hospitalized adults.
June 9, 2023
Long COVID symptoms reported by 17% of unvaccinated people
By
Elissa Wolfson
One in six unvaccinated people report persistent health impacts from COVID-19 two years after a confirmed SARS-CoV-2 infection.
June 1, 2023
COVID-19’s 'long tail' analyzed at European rheumatology congress
By
Elissa Wolfson
EULAR’s 2023 Congress includes presentations on iRD patients’ susceptibility to long COVID, and COVID-19 vaccination safety in pregnant and breastfeeding women with autoimmune disease.
May 31, 2023
FDA grants full approval for antiviral pill to treat mild-to-moderate COVID-19 in adults
By
LabPulse.com staff writers
Paxlovid is the fourth drug — and first antiviral pill — approved by the FDA to treat COVID-19 in adults.
May 25, 2023
NIH-backed project develops scoring system for identifying long-COVID patients
By
Nick Paul Taylor
While multiple earlier studies have assessed the effects of long COVID, previous efforts largely had retrospective designs, relied on electronic health record entries, and lacked an uninfected comparison group.
May 25, 2023
Domus Diagnostics gets $2.4M NIH grant to develop at-home molecular test
By
Leo O'Connor
The award, granted as part of the NIH Rapid Acceleration of Diagnostics (RADx) Tech program, will support accelerated validation and scaling of a testing platform to prepare it for a clinical trial.
May 24, 2023
Previous Page
Page 3 of 35
Next Page